Cutting Edge Technology From Japan at BIO Convention in Chicago

CHICAGO, IL--(Marketwired - Apr 10, 2013) -  The Japan External Trade Organization (JETRO) is organizing the Japan Pavilion at the 2013 BIO International Convention, to be held at Chicago's McCormick Place from Monday, April 22 to Thursday, April 25. Nineteen companies from Japan will be on display in the Japan Pavilion (Booth 3611), exhibiting some of the most innovative biotechnology from Japan.

Key technologies to be featured at the Japan Pavilion include new treatments for oncology, pain management, cognitive disorders and neurological disorders; advancements in regenerative medicine; drug discovery tools; and contract manufacturing and R&D.

Three of the companies in the Pavilion will be representing technologies developed at some of Japan's leading universities. iPS Academia Japan manages patents from Kyoto University, including the iPS pluripotent stem cells technology developed by Dr. Shinya Yamanaka, winner of the 2012 Nobel Prize for Medicine. Todai TLO, which represents technology developed by the University of Tokyo, will feature a novel treatment for cardiovascular disease. MPO Inc. will show their new regenerative medicine technique which utilizes cardiac stem cells.

The Japan Pavilion exhibitors will also participate in BIO's One-on-One Partnering meetings. The Japanese delegates are eager to meet new strategic development and distribution partners.

The annual BIO Convention, organized by the Biotechnology Industry Organization, is the largest event for the biotechnology sector, attracting over 16,000 attendees from all over the world. JETRO has organized the Japan Pavilion since 2003.

ABOUT JETRO
The Japan External Trade Organization (JETRO) is an incorporated administrative agency operating under the auspices of Japan's Ministry of Economy, Trade and Industry (METI) to promote mutual trade and investment between Japan and the rest of the world. Utilizing our network of more than 70 overseas offices and 36 in Japan, JETRO carries out a range of activities, including: facilitating foreign direct investment into Japan; helping Japan's small and medium-size firms maximize their export potential; and promoting Japanese products abroad.

In the field of biotechnology, JETRO provides market information and consulting to Japanese companies interested in entering foreign markets and to foreign companies interested in expanding into Japan. JETRO also coordinates periodic business matching opportunities at conferences and tradeshows around the world.

For more information, visit jetro.org or contact Robert Corder at JETRO Chicago.